NOAH comment on the Government response to the GB Veterinary Medicines Regulation
2nd February 2024
We welcome the publication of the Government response to the consultation on the new GB Veterinary Medicines Regulation and look forward to this vital piece of legislation being adopted. The UK animal health industry needs a robust, up-to-date regulatory process to produce the veterinary medicines necessary to protect and improve animal health and welfare in the UK.
This not only benefits animals, but also helps to protect human and environmental health while positively contributing to societal sustainability goals.
Dawn Howard, NOAH’s Chief Executive said: “It is good to see that, in a number of key areas that we felt would adversely impact animal health and welfare, Government has listened and responded to stakeholder concerns. For example, we welcome the modifications made to the labelling requirement proposals for veterinary medicines and that POM-V medicines other than antimicrobials can continue to be advertised to professional keepers of animals.
“We look forward to reviewing the detail and commend the hard work that has been done to bring this about.”
Notes for Editors
For more information contact Alison Glennon glennon@noah.co.uk or Jenny George-Town j.george-town@Noah.co.uk
NOAH represents the UK animal health industry. We promote the benefits of licensed medicines and solutions for the health and welfare of all animals.
The Government response can be found at Review of the Veterinary Medicines Regulations 2013 – Defra – Citizen Space